Qlaris Bio appointed Fred Guerard, Pharm.D., as President and Chief Executive Officer.
Qlaris Bio is a clinical stage biotechnology company developing first-in-class therapies for unmet needs in ophthalmology
Qlaris Bio is a clinical stage biotechnology company developing first-in-class therapies for unmet needs in ophthalmology. The Company’s lead candidate, QLS-111, is designed to treat glaucoma by targeting episcleral venous pressure and improving ocular perfusion.